Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Exact Sciences Cor (EXAS)

Exact Sciences Cor (EXAS)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 9,354,996
  • Shares Outstanding, K 175,945
  • Annual Sales, $ 1,767 M
  • Annual Income, $ -595,630 K
  • 60-Month Beta 1.23
  • Price/Sales 5.38
  • Price/Cash Flow N/A
  • Price/Book 2.92
Trade EXAS with:

Options Overview Details

View History
  • Implied Volatility 79.87% ( +7.17%)
  • Historical Volatility 73.26%
  • IV Percentile 96%
  • IV Rank 78.44%
  • IV High 90.34% on 04/29/22
  • IV Low 41.76% on 11/04/21
  • Put/Call Vol Ratio 0.60
  • Today's Volume 112
  • Volume Avg (30-Day) 1,199
  • Put/Call OI Ratio 1.32
  • Today's Open Interest 60,313
  • Open Int (30-Day) 59,042

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 12 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/22
See More
  • Average Estimate -1.08
  • Number of Estimates 5
  • High Estimate -0.91
  • Low Estimate -1.15
  • Prior Year -1.03
  • Growth Rate Est. (year over year) -4.85%

Price Performance

See More
Period Period Low Period High Performance
1-Month
46.15 +15.21%
on 05/12/22
67.84 -21.62%
on 04/21/22
-12.39 (-18.90%)
since 04/20/22
3-Month
46.15 +15.21%
on 05/12/22
79.85 -33.41%
on 02/28/22
-20.96 (-28.27%)
since 02/18/22
52-Week
46.15 +15.21%
on 05/12/22
133.99 -60.32%
on 06/28/21
-52.57 (-49.72%)
since 05/20/21

Most Recent Stories

More News
Catalio Capital Management Raises $381 Million for Oversubscribed Third Life Sciences Fund

Catalio Capital Management, LP (“Catalio”), a leading multi-strategy life sciences investment firm, today announced the successful close of its third venture fund, Catalio Nexus Fund III (“Fund III”...

RXRX : 5.41 (-1.99%)
CMPS : 8.36 (+0.12%)
ATAI : 4.00 (+0.76%)
EXAS : 53.17 (-1.54%)
LH : 248.55 (+0.86%)
Exact Sciences (EXAS) Q1 Earnings Top Estimates, Sales View Up

Robust performances by the Screening and Precision Oncology segments drove Exact Sciences' (EXAS) first-quarter top line.

VIVO : 25.77 (-1.15%)
ALC : 72.68 (+0.62%)
CPSI : 30.89 (-1.53%)
EXAS : 53.17 (-1.54%)
Exact Sciences (EXAS) Q1 2022 Earnings Call Transcript

EXAS earnings call for the period ending March 31, 2022.

EXAS : 53.17 (-1.54%)
Exact Sciences (EXAS) Reports Q1 Loss, Tops Revenue Estimates

Exact Sciences (EXAS) delivered earnings and revenue surprises of 7.14% and 5.35%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

EXAS : 53.17 (-1.54%)
HGEN : 2.26 (+0.89%)
Exact Sciences (EXAS) Stock Moves -0.49%: What You Should Know

Exact Sciences (EXAS) closed at $60.68 in the latest trading session, marking a -0.49% move from the prior day.

EXAS : 53.17 (-1.54%)
Exact Sciences (EXAS) to Post Q1 Earnings: What's in Store?

Robust global demand for Oncotype DX and increased Cologuard orders are likely to have driven Exact Sciences' (EXAS) Q1 performance.

VIVO : 25.77 (-1.15%)
LLY : 298.85 (+4.39%)
EXAS : 53.17 (-1.54%)
LHDX : 2.13 (-2.29%)
2 Top Biotech Stocks to Buy for the Long Haul

Repligen and Exact Sciences have a proven track record with significant opportunities for continued growth.

RGEN : 154.53 (-0.06%)
EXAS : 53.17 (-1.54%)
Here's Why You Should Hold on to Exact Sciences (EXAS) Stock

Investors are optimistic about Exact Sciences (EXAS) on strong buoyed by Cologuard volume growth.

MCK : 322.86 (+1.17%)
BIO : 522.20 (-0.21%)
AMN : 88.49 (+1.64%)
EXAS : 53.17 (-1.54%)
Exact Sciences (EXAS) Dips More Than Broader Markets: What You Should Know

In the latest trading session, Exact Sciences (EXAS) closed at $71.32, marking a -0.78% move from the previous day.

EXAS : 53.17 (-1.54%)
Exact Sciences (EXAS) Down 4.3% Since Last Earnings Report: Can It Rebound?

Exact Sciences (EXAS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

EXAS : 53.17 (-1.54%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Exact Sciences Corporation is a molecular diagnostics company focused on the early detection and prevention of some of the deadliest forms of cancer. The company has developed an accurate, non-invasive, patient-friendly screening test called Cologuard for the early detection of colorectal cancer and...

See More

Key Turning Points

3rd Resistance Point 61.06
2nd Resistance Point 58.32
1st Resistance Point 55.75
Last Price 53.17
1st Support Level 50.44
2nd Support Level 47.70
3rd Support Level 45.12

See More

52-Week High 133.99
Fibonacci 61.8% 100.44
Fibonacci 50% 90.07
Fibonacci 38.2% 79.70
Last Price 53.17
52-Week Low 46.15

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar